Management of acute myocardial infarction in Portugal. Results of a nationwide survey;Tratamento do enfarte agudo do miocárdio em Portugal. Resultados globais de um registo nacional

Revista Portuguesa de Cardiologia

Volumn 20, Issue 7-8, 2001, Pages 709-722

  Morais, J ^a   Ferreira, D ^a   Soares, R ^a   Ferreira, R ^a  

^a Hospital de Santo Andre   (Portugal)

Author keywords

Acute myocardial infarction; Fibrinolysis; National Registry; Primary angioplasty; Reperfusion therapy

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; STATINE DERIVATIVE;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; EVIDENCE BASED MEDICINE; FEMALE; FIBRINOLYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRACTICE GUIDELINE; REPERFUSION; REVASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; DATA COLLECTION; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PORTUGAL; PROSPECTIVE STUDIES; REGISTRIES;

EID: 0034826550     PISSN: 08702551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)
2. 1999 Update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)
3. Acute myocardial infarction: Pre-hospital and in-hospital management
4. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: Executive summary and recommendations. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee on the management of patients with unstable angina)
5. Management of acute coronary syndromes: Acute coronary syndromes without persistent ST segment elevation
6. Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients
7. Clinical experience with primary percutaneous transluminal coronary angioplasty compared with alteplase (recombinant tissue-type plasminogen activator) in patients with acute myocardial infarction: A report from the Second National Registry of Myocardial Infarction (NRMI-2)
8. Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction
9. Prognosis after acute myocardial infarction: A multivariate analysis of mortality and survival
10. Ventricular enlargement and remodeling following acute myocardial infarction: Mechanisms and management
11. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
12. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischemic events (CAPRIE)
13. International beta-blocker review in acute and postmyocardial infarction
14. Cardiovascular death and left ventricular remodeling two years after myocardial infarction: Baseline predictors and impact of long-term use of captopril: Information from the Survival and Ventricular Enlargement (SAVE) Trial
15. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
16. The ENACT study: A pan-European survey of acute coronary syndromes
17. Global patterns of use of thrombolytic, antithrombotic and antiplatelet therapy in patients with acute coronary events: Insights from the Global Registry of Acute Coronary Events (GRACE)
18. Management of acute myocardial infarction in intensive care units in 1995: A nationwide French survey of practice and early hospital results
19. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction: Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI)
20. Hospital mortality from acute myocardial infarction in the Czech Republic: Community hospitals versus PTCA centres (PRAGUE Study Myocardial Infarction Registry)
21. Mortality in patients with acute myocardial infarction treated with reperfusion therapy, beyond the clinical trials
22. Basis para un registro hospitalario de infartos agudos de miocardio en España
23. Prognosis after acute myocardial infarction: A multivariate analysis of mortality and survival
24. Ventricular enlargement and remodeling following acute myocardial infarction: Mechanisms and management
25. Relation of initial infarct size to extent of left ventricular remodeling in the year after acute myocardial infarction
26. GISSI trial: Early results and late follow-up
27. Patency and reinfarction in late-entry myocardial infarction patients treated with reperfusion therapy
28. Admission clinical and electrocardiographic characteristics predicting an increased risk for early reinfarction after thrombolytic therapy
29. Combining thrombolysis with the platelet glycoprotein Ilb/IIIa inhibitor lamifiban results of the Platelet Aggregation Receptor Antagonist Dose Investigation and Reperfusion Gain in Myocardial Infarction (PARADIGM) trial
30. Mortality, reinfarction, left ventricular ejection fraction and costs following reperfusion therapies for acute myocardial infarction
31. Strategies to achieve cororary arterial plaque stabilization
32. Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes. The RECIFE (reduction of cholesterol in ischemia and function of the endothelium) trial
33. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes. The MIRACL Study: A randomized controlled trial